Aemetis (NASDAQ:AMTX) Issues Earnings Results

Aemetis (NASDAQ:AMTXGet Free Report) announced its quarterly earnings data on Thursday. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.20, FiscalAI reports. The business had revenue of $43.31 million during the quarter, compared to analysts’ expectations of $72.07 million.

Aemetis Price Performance

Aemetis stock opened at $1.54 on Thursday. The company has a market cap of $101.95 million, a price-to-earnings ratio of -0.96 and a beta of 2.61. Aemetis has a 12 month low of $1.22 and a 12 month high of $3.66. The stock’s 50-day moving average is $1.53 and its 200-day moving average is $1.91.

Analyst Ratings Changes

A number of brokerages have issued reports on AMTX. Ascendiant Capital Markets cut their target price on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.00.

View Our Latest Report on Aemetis

Hedge Funds Weigh In On Aemetis

Hedge funds have recently added to or reduced their stakes in the business. Creative Planning acquired a new stake in shares of Aemetis during the second quarter worth $30,000. Virtu Financial LLC bought a new stake in shares of Aemetis during the 4th quarter valued at about $31,000. HRT Financial LP bought a new stake in shares of Aemetis during the 4th quarter valued at about $36,000. Centiva Capital LP acquired a new stake in Aemetis during the third quarter worth about $39,000. Finally, Engineers Gate Manager LP bought a new position in Aemetis in the second quarter worth about $42,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Company Profile

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

Further Reading

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.